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Abstract: Smoking remains a significant health and economic concern in the United States.
Furthermore, the emerging pattern of nicotine intake between sexes further adds a layer of complexity.
Nicotine is a potent psychostimulant with a high addiction liability that can significantly alter brain
function. However, the neurobiological mechanisms underlying nicotine’s impact on brain function
and behavior remain unclear. Elucidation of these mechanisms is of high clinical importance and may
lead to improved therapeutics for smoking cessation. To fill in this critical knowledge gap, our current
study focused on identifying sex-specific brain-derived extracellular vesicles (BDEV) signatures in
male and female rats post nicotine self-administration. Extracellular vesicles (EVs) are comprised of
phospholipid nanovesicles such as apoptotic bodies, microvesicles (MVs), and exosomes based on their
origin or size. EVs are garnering significant attention as molecules involved in cell–cell communication
and thus regulating the pathophysiology of several diseases. Interestingly, females post nicotine
self-administration, showed larger BDEV sizes, along with impaired EV biogenesis compared to
males. Next, using quantitative mass spectrometry-based proteomics, we identified BDEV signatures,
including distinct molecular pathways, impacted between males and females. In summary, this
study has identified sex-specific changes in BDEV biogenesis, protein cargo signatures, and molecular
pathways associated with long-term nicotine self-administration.
Keywords: nicotine; extracellular vesicles; sex differences; proteomics; bioinformatics
1. Introduction
Smoking remains a significant health and economic burden in the United States, resulting in
480,000 deaths and costing more than $300 billion annually [1]. While many smokers report a desire to
quit, many are unsuccessful in attempting to quit. The robustness of this addiction can be partially
attributed to nicotine, the primary addictive component in cigarettes [2]. Nicotine is a well-known
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psychostimulant that diffuses readily into brain tissue, where it binds to nicotinic acetylcholine receptors
(nAChRs) [3]. Activation of these receptors produces a wide variety of short and long-term effects
on various organ systems. There are now a variety of well-known sex differences associated with
smoking. Women are more likely to smoke fewer cigarettes per day compared to men, and they also
have a higher nicotine dependence [4,5]. This may be due to motivations associated with smoking [6].
Generally, women also smoke in response to non-nicotine stimuli. This response to non-nicotine
stimuli may help explain why women have greater difficulty in quitting compared to men. Research
has also shown that men tend to improve cessation rates through nicotine interventions, while women
do better with non-nicotine interventions such as counseling [7,8]. These differences suggest that
women have a higher sensitivity to non-pharmacokinetic effects of nicotine [9]. Though there are many
environmental and societal factors that play a role in nicotine sex differences, there are also biological
factors to consider. Previous research emphasizes the developmental impact of nicotine on sexual
differentiation and explains how prenatal and adolescent nicotine exposure can have sex-specific effects
due to changes in circulating gonadal hormones [10]. In addition to the changes in circulating gonadal
hormones, there is an impact at the molecular level with the differential expression of X and Y genes.
These biological factors, as a result, impact neuronal composition and functions like memory, cognitive
function, and reward processing.
In tandem, pre-clinical animal models have shown nicotine associated sex differences. Female rats
self-administer nicotine at lower doses and have higher intake in socially-acquired self-administration
with more motivation to obtain nicotine [11–15]. Female rats also show greater nicotine-induced
locomotor sensitization, higher sensitivity to nicotine conditioning, and increased withdrawal
signs [16]. Previous research on reinforcing effects using the nicotine self-administration task has also
helped explain the associated pathways and neurotransmitter systems critical to nicotine addiction.
The mesocorticolimbic pathway has been shown to play an essential role in nicotine self-administration,
where the ventral tegmental area (VTA) is the primary site responsible for the reinforcing effects of
nicotine [17]. Another brain region of particular interest is the prefrontal cortex (PFC), as it may play
a role in sex differences associated with nicotine self-administration. For example, neurotensin, a
neuropeptide, is increased in the PFC of male rats but not in females after nicotine self-administration
in comparison to saline controls [9].
While research has established the likely importance of sex differences in the behavioral and
neural effects of nicotine, there is a significant knowledge gap in discerning the molecular mechanisms.
One such critical regulator is an extracellular vesicle (EV); extracellular vesicles are phospholipid
nanovesicles that include, based on their origin or size, apoptotic bodies, microvesicles, and exosomes.
These EVs are garnering significant attention as molecules involved in cell–cell communication
between cells and regulating the pathophysiology of several diseases [18–20]. EVs carry molecular
cargo such as proteins, lipids, and RNA [21–23]. The molecular composition of the EV-cargo
generally depends on their cells/tissue of origin. Furthermore, recent works have depicted their role
as next-generation biomarkers based on their feasibility as therapeutic drug-delivery nanocarriers.
In immunotherapy, they have generated much excitement as candidates for diagnostics and therapeutics
in an array of diseases [24–28]. In this current study, we performed ultrastructural characterization of
BDEV, their biogenesis, and identification of signatures using quantitative mass spectrometry-based
proteomics from male and female Sprague Dawley rats following either long-term nicotine or saline
self-administration. Further, employing bioinformatics analysis, we identified distinct biological
processes associated with differentially expressed proteins of BDEV between males and females. To our
knowledge, this is the first study to identify sex-specific changes in BDEV biogenesis, protein cargo
signatures, and molecular pathways associated with long-term nicotine self-administration.
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2. Materials and Methods
2.1. Self-Administration and Brain Tissue Collection
The brain tissue used in this study was from a previously published work from our group [29].
Briefly, 9-week-old male and female Sprague Dawley rats were trained for lever presses following
which rats were surgically implanted with a jugular catheter (IUCAC #1477 and Animal Welfare
Assurance Number A3459-01). After recovery, rats received 1 h training sessions with sucrose available
on a variable ratio (VR) 3 schedule of reinforcement for 1 week following which rats were randomly
distributed to perform self-administration of either nicotine (0.03 mg/kg/infusion) or saline on a VR3
schedule. The self-administration sessions were conducted for 22 days. Twenty-four hours after the
last self-administration session, brains were extracted and stored at −80 ◦C until further use. Figure 1
shows further steps carried out after brain tissue isolation.
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The goal here as to identify B E s as potential arkers associated ith nicotine dependency
between male and fe ale rats. f note, e un erstan that the ethodology to isolate extracellular
vesicles should be co ple e te it t er tec i es, t t ere are arious published studies on
those fronts. In this current study, we p rformed BDEV isolati n fr m rats in all four treatment groups
(n = 4–6 per group) using the s crose density, which is well established in our lab, as evidenced by our
previous pu lications [30–32]. Briefly, brain tissue was minced and digested in 20 units/mL papain in
Hibernate A (Life Technologies, Waltham, CA, USA). Digestion was then followed by the immediate
addition of cold Hibernate A to st p the enzymatic digestion. Cells, large particles, and d bris were
removed via multiple c ntrifugations (300× g, 2000× g, 10,000× g) and filtered through a 0.22 µm
filter. To ens re maximum concentration of EVs, samples were then ultra-centrifug d at 100,000×
g for an hour at 4 ◦C, followed by its purification using a density gradient separation techn que.
Sucrose c c ntrations ranging fr m 0.25 to 2 M were used for the density gradient separa ion, a d he
concentrated EVs pellet was resuspended in the 0.95 M l yer and ultra-ce trifuged at 200,000× g fo 16
h at 4 ◦C. Fractions enhanced with EVs were subjected to a ditional ultrac ntrifugation t 100,000×
g to obtain the purified EVs pellet. These EV pellets were then re-suspended in 1× particle-free
phosphate-buffered saline (PBS) and protein content measured using bicinchoninic acid assay (BCA).
2.3. Western Blot: BDEV Marker Validation
The purity of BDEVs was determined through specific antibodies described in previous
studies [30–32]. Briefly, BDEV protein lysates were prepared using RIPA buffer with 1% SDS and
protease-phosphatase inhibitor following which 40 µg of protein (for positive markers) and 10 µg (for
the negative marker) from a control brain run on 4% to 12% Bis-Tris gels (Invitrogen, Waltham, MA,
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USA) under reducing (Hsp70, flotillin, and calnexin) and non-reducing conditions (CD81) followed by
transfer using iBLOT2 (Invitrogen). Nonspecific antibody binding was done using 5% nonfat dried milk.
Immunoblotting was carried out with primary antibodies at 4 ◦C against the positive BDE markers
Hsp70 (1:1000, Sigma, St. Louis, MO, USA), flotillin-1 (1:1000, Abcam, Cambridge, UK), CD81 (1:500,
Bio-Rad, Hercules, CA, USA), and the negative marker calnexin (1:1000, Abcam) followed by secondary
antibody (1:2500 HRP conjugated anti-mouse IgG for Hsp70, 1:2500 HRP conjugated anti-rabbit IgG for
flotillin-1, 1:1500 HRP conjugated anti-hamster IgG for CD81, and 1:2000 HRP conjugated anti-rabbit
IgG for calnexin). Blots were developed with 1:1 solution of Radiance Chemiluminescent Substrate and
Luminol/Enhancer (Azure Biosystems, Dublin, CA, USA). A c300 imaging system (Azure Biosystems)
was used to visualize the blots, and images acquired were quantified using the ImageJ software
version 1.52a.
2.4. Nanoparticle Tracking Analysis (NTA)
EV size distribution curves and concentration measurements were carried out by NTA using
a Nanosight NS300TM (Malvern Instruments, Malvern, UK). For NTA analysis, BDEV pellets were
resuspended in 100 µL PBS of which 10 µL of the sample was diluted to 1:100–1:1000 in PBS prior
to measurements. All samples were loaded with the laser module outside the instrument. As the
sample was loaded, care was taken to avoid air pockets. The machine was equipped with a 488 nm
laser and a syringe pump system, with a pump infusion speed of 20. The standard measurement
option was selected for the scripted workflow to capture videos. The number and duration of captures
were set to 5 and 60 s, respectively. The base filename and location were selected prior to starting
the run. The camera level was set at 11. Background measurements were performed with filtered
PBS, which revealed the absence of any kind of particles. Five video recordings were carried out for
each EV preparation with a duration of the 60 s with frame rates of 25 frames/s. Once the videos were
recorded, the NTA 3.1 software version was used to analyze the sample videos. For analysis, the screen
gain was set to 1.0, and the detection threshold was adjusted to set the minimum brightness of pixels
to be considered. At the end of the analyses, the dilution factor for the samples was updated before
data export.
2.5. Transmission Electron Microscopy (TEM)
TEM analysis was performed as described in our recently published study [31]. Briefly,
BDEVs pellets were resuspended in 1× PBS. Then, 90 µL of TEM fix buffer (2% glutaraldehyde,
2% paraformaldehyde, and 0.1 M phosphate buffer) was mixed with 10 µL of BDEVs suspension.
A 10-µL drop of BDEVs-buffer solution was spotted on 200-mesh copper grid coated with formvar and
silicon monoxide and allowed to incubate for 2 min. The excess solution was taken off by filter paper,
and the thin film of sample was allowed to air dry for 2 min. Using a NanoVan (Nanoprobes, New
York, NY, USA), the samples were negatively stained on the grid. The excess negative stain was then
taken off by filter paper and allowed to dry for at least 1 min before being imaged. Grids were assessed
on a Tecnai G2 TEM (built by FEI, Hillsboro, OR, USA) functioned at 80 kV. An advanced microscopy
techniques digital imaging system was used to acquire digital images.
2.6. Total RNA Isolation, cDNA Preparation, and Quantitative Real-Time PCR
Total RNA was isolated from individual rats from both sexes and treatment groups using
the Direct-Zol RNA kit (Zymo Research, Irvine, CA, USA) based on the manufacturer’s protocol.
Quantitation of extracted total RNA and RNA integrity was determined by Epoch (BioTek, Winooksi,
VT, USA). cDNA was prepared from the respective samples using the Superscript IV kit (Invitrogen,
Waltham, MA, USA), and thereafter RT-PCR was performed using TaqMan Custom Array Plates
for genes involved with the endosomal sorting complexes required for transport (ESCRT) pathways.
The expression of the following 28 genes were analyzed: HGS, STAM, STAM2, MVB12A, MVB12B,
TSG101, UBAP, VPS28, VPS37A, VPS37B, VPS37C, VPS37D, SNF8, VPS25, VPS36, CHMP2A, CHMP2B,
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CHMP3, CHMP4B, CHMP4C, CHMP6, VPS4A, VPS4B, Cers2, Cers3, Cers4, Cers5, and Cers6 with
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as control. The Delta-delta Ct method was
used to calculate fold change and statistical significance [30].
2.7. Mass Spectrometry/Proteomics
Label free quantitative mass spectrometry was performed as described in an earlier study [33].
A 50 µg sample of protein per group was taken, and detergent was removed by chloroform/methanol
extraction, and the protein pellet was re-suspended in 100 mM ammonium bicarbonate and digested
with MS-grade trypsin (Pierce, Dallas, TX, USA) overnight at 37 ◦C. Peptides were cleaned with
PepClean C18 spin columns (ThermoFisher, Waltham, MA, USA) and re-suspended in 2% acetonitrile
(ACN) and 0.1% formic acid (FA). Of each sample, 500 ng was loaded onto trap column Acclaim
PepMap 100 75 µm × 2 cm C18 LC Columns (Thermo Scientific, Waltham, MA, USA) at flow rate of 4
µL/min, then separated with a Thermo RSLC Ultimate 3000 (Thermo Scientific) on a Thermo Easy-Spray
PepMap RSLC C18 75 µm × 50 cm C-18 2 µm column (Thermo Scientific) with a step gradient of
4–25% solvent B (0.1% FA in 80% ACN) from 10–130 min and 25–45% solvent B for 130–145 min at 300
nL/min and 50 ◦C with a 180 min total run time. Eluted peptides were analyzed by a Thermo Orbitrap
Fusion Lumos Tribrid (Thermo Scientific) mass spectrometer in a data-dependent acquisition mode. A
full survey scan MS (from m/z 350–1800) was acquired in the Orbitrap with a resolution of 120,000.
The AGC target for MS1 was set as 4 × 105 and ion filling time set as 100 ms. The most intense ions
with charge state 2–6 were isolated in a 3 s cycle and fragmented using HCD fragmentation with 40%
normalized collision energy and detected at a mass resolution of 30,000 at 200 m/z. The AGC target
for MS/MS was set as 5 × 104 and ion filling time set 60 ms dynamic exclusion was set for 30 s with a
10-ppm mass window. Protein identification was performed by searching MS/MS data against the
swiss-port Rattus norvegicus protein database, using the in-house mascot 2.6.2 (Matrix Science, Boston,
MA, USA) search engine. The search was set up for full tryptic peptides with a maximum of two
missed cleavage sites. Acetylation of protein N-terminus and oxidized methionine were included
as variable modifications, and carbamidomethylation of cysteine was set as a fixed modification.
The precursor mass tolerance threshold was set 10 ppm for, and maximum fragment mass error was
0.02 Da. The significance threshold of the ion score was calculated based on a false discovery rate of
≤1%. Qualitative analysis was performed using Progenesis QI proteomics 4.1 (Nonlinear Dynamics,
Milford, MA, USA).
2.8. Bioinformatics Analysis
Gene Ontology (GO) analysis of differentially expressed proteins was performed using the
Cytoscape plugin ClueGO [34]. Only proteins exhibiting significantly different expression across
nicotine vs. saline comparison were included in this analysis. Biological process, molecular function,
along with KEGG pathways, were included for GO enrichment analysis. Heatmaps were generated for
differentially expressed proteins in each comparison using the function heatmap.2 in the R (version
3.6.0) package gplots.
2.9. Statistical Analysis
For proteomics analysis, after normalization, a student t-test was done to identify proteins showing
significant differences between groups (saline versus nicotine for each of the sexes). Proteins that had
at least two unique peptides and a t-test p-value < 0.05 were considered significant. For the ESCRT
analysis, a 2-way ANOVA followed by Sidak’s multiple comparison test with p < 0.05 was considered
significant. All statistical tests were performed and analyzed with GraphPad Prism (La Jolla, CA,
USA); data represented as mean ± SEM on the graphs.
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3. Results
3.1. Nicotine Exposure Increases BDEV Size Which Is More Pronounced in Females
Our previously published study revealed that male and female rats readily self-administered
nicotine, while yoked saline maintained very little responding [29]. In addition, we also reported
that female rats had a significantly higher total nicotine intake than males, which is consistent with
previously published papers [11,14,15,35–37]. Based on this observation, we hypothesized that nicotine
intake impacts the BDEV sizes in males and females. Accordingly, we isolated BDEV from the different
treatment groups using a sucrose density gradient ultracentrifugation method, as described in our
previous studies [30–32]. To further ascertain the purity of isolated BDEV, we performed Western
blot analysis using positive and negative EV markers, which were established by the International
Society for Extracellular Vesicles [38]. Figure 2A,B shows the presence of the positive markers Hsp70,
Flotillin-1, and CD81 in the BDEVs and absence of negative marker calnexin. NTA analysis showed a
slight increase in the number of BDEVs released in both males and females post nicotine exposure but
were overall not significant (Figure 2C).
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Figure 2. Validation of BDEV purity. (A) Western lot analysis on BDEV is lated f m a control saline
animal shows the expression of the positive markers CD81, flotillin-1, and Hsp70. (B) The negative
marker calnexin was enriched in the whole tissue lysate (L) but absent in the EVs fraction (EV). (C) Nano
tracking analysis (NTA) hows an in rease in BDEV parti le concentration in b th and male and female
rats exposed to nicotine. However, no significant changes in concentrations of isolated BDEVs from the
two treatment groups between the sexes was observed as determined by a 2-way ANOVA followed by
Sidak’s multiple comparison test.
TEM analysis of BDEV revealed a cup-like appearance of vesicles. While the BDEV sizes for the
saline animals were around 85 nm and 140 nm, nicotine self-administration caused an increase in
vesicle size, which was more pronounced in the females (Figure 3A,B).
3.2. Nicotine Increases BDEV Biogenesis Which Are More Pronounced in Females
Based on the increase in the BDEV size with nicotine, we then assessed whether EV biogenesis was
also altered between males and females. EV biogenesis depends on several genes, including the ESCRT
pathway [39,40] and ESCRT independent pathways such as the ceramide synthesis pathway [41].
Total RNA from males and females from the saline and nicotine groups was analyzed using a multiplex
RT-PCR array. Several genes involved in the ESCRT dependent and independent pathways were
significantly upregulated and more pronounced in the females. Specifically, genes belonging to the
families ESCRT-0: HGS, STAM1 and 2; ESCRT-I: MVB12A and B, TSG101, UBAP1, VPS37A and D;
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ESCRT-II: VPS25; ESCRT-III: CHMP2A and 6; and the disassembly complex: VPS4A and B were
significantly elevated in the female rats post nicotine self-administration. Further, we also found
an upregulation of genes in the ceramide synthesis pathway such as CERS2, CERS4, 5, and 6 in the
females (Figure 4). Together, these data indicate that the ESCRT and ceramide pathways were affected
by chronic nicotine exposure and are further pronounced in females.
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Figure 3. Characterization of BDEV. (A) BDEV isolated using a sucrose density gradient from the three
groups were characterized using TEM that revealed increased sizes in both males and females which
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(B) Average BDEV sizes. Average BDEV sizes for each group is represented as mean ± SEM, * p < 0.05
as determined by a 2-way ANOVA followed by Sidak’s multiple comparison test.
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3.3. Proteomics and Bioinformatics Analysis
To further corroborate that increased BDEV size and altered biogenesis with chronic nicotine
intake also leads to changes in BDEV cargo, we used quantitative mass spectrometry-based proteomics
to identify changes in the BDEV proteins between males and females. A total of 2165 and 2051 proteins
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were identified between males and females, respectively (Supplementary Table S1). Further employing
a criterion of 2+ unique peptides, and p < 0.05, we identified 85 proteins and 31 proteins to be
differentially expressed between males and females respectively (Supplementary Table S2). Figure 5A
shows the Venn diagram of the differentially expressed proteins with saline and nicotine treatment
among males and females. Ten proteins were significantly upregulated with nicotine for females,
while six were upregulated in males. On the other hand, 21 proteins were significantly downregulated
for females with nicotine, while 79 were downregulated for males. A heatmap was then generated
based on the significant differentially expressed proteins between nicotine and saline groups for both
male and female as shown in Figure 5B,C. Table 1 shows the distinct significant proteins for each sex to
be expressed 1.5-fold up or down with nicotine exposure.
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Table 1. Significant proteins differentially expressed between males and females after nicotine
self-administration. A criterion of 2+ unique peptides and fold change of >1.5 was used to select the
potential hits.
Group Accession Number Gene Name Fold Change
Males
F1MA89 Cyclin Y +2.1
A0A0G2K127 Vascular cell adhesion protein 1 +1.6
P62749 Hippocalcin-like protein 1 −1.5
F8WFM2 Beta-soluble NSF attachmentprotein −1.5
Q5XIE8 Integral membrane protein 2B −1.5
Q9EQX9 Ubiquitin-conjugating enzyme E2 −1.5
Q9Z1B2 Glutathione S-transferase Mu 5 −1.5
D3Z981 Plexin A1 −1.5
Q05683 Glutamate decarboxylase 2 −1.6
Q05982 Nucleoside diphosphate kinase A −1.6
P04631 Protein S100-B −1.6
P15205 Microtubule-associated protein 1B −1.6
P31647 Sodium- and chloride-dependentGABA transporter 3 −1.6
A0A0G2K9J2 V-type proton ATPase subunit H −1.6
P08009 Glutathione S-transferase Yb-3 −1.6
Q6PW52 GABA-A gamma2 long isoform −1.8
A0A0G2K5E7 ATP-citrate synthase −1.9
D4A8N1 Dolichol-phosphatemannosyltransferase subunit 1 −2.0




Q9R0I8 Phosphatidylinositol 5-phosphate4-kinase type-2 alpha +1.7
Q5U2 × 8 Acyl-CoA thioesterase 9 +1.6
G3V7Q6 Proteasome subunit beta −1.5
Next, the enriched biological processes of these differentially expressed proteins were determined
for both male and female through ClueGO analysis that revealed several enriched biological processes
for the males: receptor internalization, synaptic vesicle cycle, glutathione metabolism, GPI anchor
metabolic process, GABAergic synapse, cardiac conduction, glial cell proliferation, and N-glycan
biosynthesis (Figure 6). For the females, the enriched biological processes included bile secretion,
gastric secretion, and axon regeneration. As shown in Figure 6, there are various gene ontology
terms involved at the neuronal level, such as axon regeneration, synaptic vesicle cycle, glial cell
proliferation, and GABAergic synapse. Axon regeneration was more specific to the female group,
while synaptic vesicle cycle, glial cell proliferation, and GABAergic synapse were specific to the male
group. These data suggest that nicotine treatment does have an impact on BDEVs and potentially
impairs important neuronal functions.
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4. Discussion
Our previously published study demonstrated the impact of nicotine on sex differences through
a drug self-administration model that mimics human drug-taking behavior [29]. Though male and
female rats readily self-administer nicotine, female rats had a significantly higher total nicotine intake
than males (+1.35 fold). This result is evident with many previously published works [11,14,15,35–37].
While many studies have acknowledged various behavioral factors for observed sex differences
associated with chronic nicotine intake, the molecular mechanisms contributing to these sex differences
remain poorly explained. To fill this critical knowledge gap, the current study focused on elucidating
the role of BDEVs in sex differences associated with nicotine self-administration. EVs are vesicles
secreted by cells and carry cellular cargo such as microRNA and proteins. They range from 30 to 120 nm
in size and regulate several pathophysiological processes like inflammation and tumor growth [42–44],
thus denoting their potential as valuable diagnostic markers and therapeutic vehicles [45,46].
Studies examining the effect of smoking and EV release have shown an increase in EV number and
sizes. For example, one study that assessed the bronchoalveolar lavage from smokers with non-small
cell lung cancer showed an increase in EV particle release, which subsequently led to an increase in EV
microRNA expression compared to healthy controls [47]. Another study using airway epithelial cells
exposed to cigarette smoke extract also showed an increase in EV particle release that was prevented
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by scavenging thiol anti-oxidants N-acetyl-L-cysteine or glutathione [48]. Corsello et al. also showed
airway epithelial cells exposed to environmental tobacco smoke displayed an increase in EV size that
further lead to enhanced EV cargo content [49]. Furthermore, a recent study examining the effects
of e-cigarettes containing nicotine revealed an increase in endothelial and platelet-derived EVs in
healthy volunteers [50]. Our current observation that chronic nicotine treatment caused an increase
in both BDEV concentration and size in males and females further bolsters these above-mentioned
studies. Interestingly, the differences in BDEV size and concentration were more pronounced in females.
One possible reason that could be associated with the increased concentration and sizes of BDEV in
females could be due to the higher intake of nicotine. Yet another logical explanation could be the stage
of estrous, which has been associated with the observed sex differences with drugs of abuse [51,52].
Data from earlier studies have shown that intact female rats show higher behavioral response to
psychostimulants such as cocaine in estrus compared to other stages of the estrous cycle [53] or to
males [54]. This observation further illustrates support from another study, which showed females
reaching higher breaking points during estrous than during other stages of the estrous cycle on a
progressive ratio of cocaine self-administration [55].
Another important feature associated with EVs is their biogenesis, which is frequently dysregulated
in several pathologies [55]. This biogenesis is mediated by several proteins involved in their maturation
and trafficking. One such group of proteins is the endosomal sorting complexes required for transport
(ESCRT) machinery as well as members of the Rab family of small GTPases [56]. ESCRT dependent
and independent pathways play a major role in EV biogenesis [57]. Four different ESCRTs have been
identified, ESCRT 0, I, II, and III [58]. ESCRT 0 recognizes ubiquitinated proteins on the outside of the
endosomal membrane [59]. ESCRT I and II are recruited to the cytosolic side of the early endosomes
via various stimuli [59]. We identified the ESCRT complex 0 proteins (HGS, STAM1/2), complex I
(MVB12A/B, TSG101, UBAP1, VPS37A/D), complex II (VPS25), and complex III (CHMP2A, 6 along
with VPS4A/B and VTA1) to be significantly elevated in the females from our qRT-PCR analysis.
HRS is responsible for the secretion of small EVs (<50 nm), whereas STAM1/2 are crucial for the
secretion of larger sized EVs (>100 nm). The heterogenous population of BDEVs observed in our
findings indicates that similar pathways might be responsible for increased EV biogenesis during
chronic nicotine treatment and more perturbed in females. ESCRT-I complex mediates the sorting of
ubiquitinated cargo protein from the plasma membrane to the endosomal vesicle.
The significant increase in the expression of ESCRT-I proteins, such as MVB12A/B, UBAP1,
TSG101, and VPS37A/D, in the females possibly denotes more translocation of the protein cargo to
the endosome. In addition, some ESCRT-1 complex proteins such as TSG101 and VPS28 have been
linked to autophagy, a process that regulates the removal of dysfunctional cellular components [59].
Although nicotine exposed female rats had an increase in the expression of VPS28, it was not significant.
However, the rats with a significant increase in TSG101 expression possibly have increased autophagy.
A previous study demonstrated that knockdown of HRS, STAM1, and TSG101 decreased the total
exosome secretion [39]. Based on the increased expression of these critical regulators of exosome
secretion in the females post nicotine intake, knocking these down could possibly decrease exosome
secretion and relevant cargo. It has been suggested that ESCRT I and II are the initiators and drivers of
the intraluminal membrane budding, whereas ESCRT III completes this process [58,60,61]. Further,
the ESCRT-II-ESCRT-III interaction coordinates the sorting of ubiquitinated cargo with the budding
and scission of intralumenal vesicles into multivesicular bodies [61]. The significant up-regulation of
the complex II protein VPS25 and of complex III CHMP2A and CHMP6 in the females post nicotine
exposure denotes enhanced sorting of ubiquitinated cargo for degradation.
In addition to the ESCRT dependent pathway, independent mechanisms regulating EV biogenesis
in the absence of ESCRTs have been documented [62]. One such pathway is ceramide biosynthesis
that includes key genes: CERS2, 3, 4, 5, 6, and NSMASE2 have been previously shown to be involved
in EV biogenesis and release [62]. Ceramide is one of the lipids critical for exosome formation [63].
Emerging research points to the role of the presence of such lipid enriched molecules on EV membranes
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in several signaling pathways in disease states such as cancer. Furthermore, a recent study showed
increased levels of very long chain C24:1 ceramide in serum EVs of older women with a similar effect in
rhesus macaques compared to the respective younger groups suggesting its implication in aging [64].
CERS2 is the primary synthase involved in synthesizing very long chain C24:1 ceramide through the de
novo pathway, whereas NSMASE2 is primarily involved in the production of ceramide by hydrolysis
of sphingomyelin. Elevated ceramide levels have been associated with poor cardiovascular health
and memory impairment in older adults [65,66]. In our current study, the expression levels of CERS2
along with 4, 5, and 6 were significantly upregulated in the females after nicotine self-administration,
while CERS3 was downregulated, albeit not significantly, which could suggest the vulnerability of
females dependent on nicotine to faster aging.
EVs contain selective repertoires of proteins, RNAs, lipids, and metabolites that moderate signaling
pathways in the recipient cells [67,68]. Our current study did identify differentially expressed proteins
between males and females post nicotine exposure. Notably, the number of significantly altered proteins
after nicotine self-administration was lower in females compared to males. A logical explanation
could be the larger BDEV sizes, as observed with TEM analysis. In addition, the altered biogenesis,
as observed from the elevated expression of key ESCRT dependent and independent proteins, could
possibly lead to enhanced release of protein cargo and targeted to the endolysosome for degradation.
Among the females, Aquaporin-1 (AQP1), a membrane channel important for maintaining the
osmotic gradient, was upregulated 2-fold with nicotine exposure. A recent study demonstrated that
nicotine induces lower urinary tract symptoms that reduce bladder blood flow and subsequently
inducing urothelial hypoxia [69]. From a CNS perspective, AQP1 increase on BDEV by nicotine could
possibly be associated with inducing alterations in cerebral vasculature that further could lead to
brain dysfunction.
Another protein that was downregulated (–1.5 fold) with nicotine in females is the proteasome
subunit beta (PSMB) essential for maintaining protein homeostasis. Previous research has shown
that nicotine, at the concentration of smokers, significantly reduces proteasomal activity [12].
Since proteasome catalyzes the degradation of many proteins associated with various biological
processes, downregulation of PSMB possibly results in the accumulation of more toxic cargo protein
on the BDEVs, which subsequently could exacerbate neurodegeneration in the females.
Amongst the males, Cyclin Y (CCNY) was upregulated 2.1 fold. CCNY plays a significant role
in regulating the cell cycle and transcription. Previously published research has established that
cyclins are associated with nicotine addiction [70]. CCNY has also been shown to impact several
biological processes, including learning and memory [71]. This suggests that males are potentially
more vulnerable to higher cognitive decline with nicotine dependency. Furthermore, among the males,
we found the expression of mesoderm-specific transcript homolog protein (MEST) to be downregulated
2.7-fold. MEST consists of hydrolase function and may play a role in development. Currently, there is
no literature examining the impact of nicotine addiction and MEST, but further studies examining the
effect of nicotine on its hydrolase activity may possibly yield more mechanistic insights.
Next, we examined the key biological processes associated with differentially expressed proteins.
One key biological process we observed in the males was receptor internalization. Many studies
have shown that chronic exposure to nicotine impacts the number and localization of nAChRs.
Previous research has shown that chronic exposure to nicotine results in an increase in nicotine
binding sites [72–74]. There are various theories regarding the mechanism for the upregulation of
nAChR expression, which includes a decrease in receptor internalization. The decrease in receptor
internalization is due to conformational changes caused by nicotine, which prevents the removal of the
receptors from cell surfaces [70,75]. The enrichment of this particular biological process could mean
that male rats, which also self-administer nicotine may have increased binding and thus decreased
removal of the nAChRs from the cell surfaces. Another enriched biological process among male rats is
the synaptic vesicle cycle, which is associated with neurotransmission. Earlier research has shown that
numerous addictive drugs, including nicotine, enhance neuronal firing beyond the norm and alter the
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release probability from the presynaptic terminal [71]. While smoking, the nicotine levels are assumed
to desensitize the dopamine terminal presynaptic nAChR, but this is overcompensated for by the
high-frequency neuronal firing activity, and as a result, nicotine promotes dopamine neurotransmission.
With the enhancement of dopamine neurotransmission, there is also an increase of the readily releasable
pool of synaptic vesicles [71], thus suggesting enhanced synaptic vesicle dynamics in male rats after
nicotine exposure.
A third enriched biological process among male rats exposed to nicotine is glutathione metabolism.
Glutathione plays an important role in antioxidant defense, nutrient metabolism, and regulation of
cellular events. A deficiency of glutathione results in oxidative stress which leads to the pathogenesis of
many diseases like Alzheimer’s and Parkinson’s. Research has shown that cigarette smoking leads to an
accumulation of reactive oxygen species (ROS), which potentially leads to osteoporosis due to a decrease
in bone mineral density and impaired fracture healing [76]. Another study has shown that cigarette
smoke extract affects the ROS level as well as decreases the reduced glutathione (GSH) concentration
along with altering expression of several antioxidant enzymes in human bronchial epithelial cells [77].
Many animal models have shown the same effect of a decrease in reduced glutathione. One study
found that the levels of GSH were reduced in the cerebellum, medulla oblongata, and hemisphere
regions after young Wistar rats received a single dose of nicotine [78]. Another study with mice
showed a significant decrease in GSH in the lungs after daily nicotine injections for several weeks [79].
Based on these studies, BDEVs could consist of key proteins associated with glutathione metabolism.
While the male group revealed many enriched biological processes, there were only three revealed
among the female group: bile secretion, axon regeneration, and gastric acid secretion. There are
numerous studies that have examined the effect of nicotine on gastric acid secretion, however, the role
of nicotine remains elusive. Studies have shown that chronic nicotine administration increases the
gastric acid output, which is consistent with the fact that nicotine administration can lead to an increase
in muscarinic receptor sensitivity, which as a result, leads to gastric acid secretion [80]. Research has
also shown the amount of gastric acid secretion is associated with the number of cigarettes smoked,
and smoking over a period a time results in pentagastrin-induced gastric acid output [81]. On the other
hand, researchers have also shown that gastric acid secretion is inhibited by nicotine [80]. One study
has shown that the gastric acid output after one hour of vagal stimulation was lower among human
subjects on smoking days compared to non-smoking days [80].
Gastric acid secretion goes hand in hand with the second enriched biological process among
females: bile secretion. Smoking has been shown to increase bile salt reflux rate and bile salt
concentration, which, as a result, increases the risk for duodenogastric reflux leading to ulceration [82].
Research with the addictive component itself, nicotine, has also shown an increase in bile acid
concentration. One study with rabbits receiving low, medium, and high doses of nicotine for 14 days
revealed an increase in bile acid concentration across all groups with the highest being of the low dose
nicotine group [83]. Our data shows that smoking leads to an increase in gastric acid and bile acid
secretion, predisposing females dependent on nicotine to cancers and other diseases [84]. The final
enriched biological process among females is axon regeneration. If neuronal damage occurs, nicotine is
shown to have more negative effects in the healing process, including axon regeneration [85]. However,
research has also shown nicotine to be beneficial in relation to some diseases like multiple sclerosis.
Multiple sclerosis is a disease that leads to CNS inflammation, demyelination, and axonal damage.
Nicotine exposure in mice has shown that nicotine “betters” the axonal damage meaning it helps in
the regeneration of axons [86]. In the current context, enrichment of this pathway in the BDEV protein
cargo of females possibly indicates a neuroprotective effect against the increased intake of nicotine.
To summarize, this current study has identified unique enriched biological processes amongst
BDEVs of male and female rats post nicotine self-administration. Future works include the validation
of unique differentially expressed proteins found within these enriched biological processes for each
sex. Additionally, studies aimed at dissecting mechanisms associated with the various enriched
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biological processes will lead to significant insight into understanding the sex differences associated
with nicotine self-administration.
5. Conclusions
To summarize, this current study for the first time showed alterations in BDEV biogenesis and
protein cargo by self-administration of nicotine in both male and female rats, which were further
pronounced in the latter. Furthermore, we identified sex-specific BDEV protein signatures, including
key biological processes that could further help our understanding of the mechanisms of sex differences
with nicotine dependency.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4409/9/8/1883/s1,
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